Daniel Glaubiger
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Neutropenia and Cancer Infections
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- DNA and Nucleic Acid Chemistry 9
- Cancer therapeutics and mechanisms 9
- DNA Repair Mechanisms 3
- Biochemical and Molecular Research 3
- Oncology 18
- Cancer Treatment and Pharmacology 5
- Co-authors
- Kurt W. Kohn (9 shared papers)Warren E. Ross (3 shared papers)A Ramu (7 shared papers)Z Fuks (2 shared papers)David G. Poplack (7 shared papers)Ian Magrath (3 shared papers)Michael J. Waring (2 shared papers)John S. Holcenberg (4 shared papers)
- Journals
- Cancer (4 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Biopolymers (2 papers)Journal of Surgical Oncology (1 paper)Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (1 paper)
- Partner nations
- United StatesMalaysiaIndia
In The Last Decade
Daniel Glaubiger
51 papers receiving 2.5k citations
Daniel Glaubiger's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.0k
- Toxicology 135
- Otorhinolaryngology 91
- Molecular Biology 1.3k
- Cancer Research 238
Countries citing papers authored by Daniel Glaubiger
This map shows the geographic impact of Daniel Glaubiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Glaubiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Glaubiger more than expected).
Fields of papers citing papers by Daniel Glaubiger
This network shows the impact of papers produced by Daniel Glaubiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Glaubiger. The network helps show where Daniel Glaubiger may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Glaubiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Qualitative and quantitative aspects of intercalator-induced DNA strand breaks Hit paper breakdown → | 1979 | 231 |
| 2 | Protein-associated DNA breaks in cells treated with adriamycin or ellipticine Hit paper breakdown → | 1978 | 228 |
| 3 | 1979 | 198 | |
| 4 | Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. | 1984 | 172 |
| 5 | Intercalative binding of ellipticine to DNA. | 1975 | 134 |
| 6 | L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. | 1981 | 131 |
| 7 | Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells. | 1983 | 104 |
| 8 | 1987 | 103 | |
| 9 | 1978 | 102 | |
| 10 | 1980 | 85 | |
| 11 | Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. | 1981 | 81 |
| 12 | 1981 | 79 | |
| 13 | 1980 | 74 | |
| 14 | Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. | 1984 | 72 |
| 15 | 1983 | 69 | |
| 16 | 1986 | 62 | |
| 17 | Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells. | 1984 | 57 |
| 18 | Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity. | 1979 | 57 |
| 19 | 1980 | 54 | |
| 20 | 1974 | 47 |
About Daniel Glaubiger
Daniel Glaubiger is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Rheumatology, having authored 51 papers that have together received 2.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), DNA and Nucleic Acid Chemistry (9 papers), Cancer therapeutics and mechanisms (9 papers), Acute Lymphoblastic Leukemia research (5 papers), Cancer Treatment and Pharmacology (5 papers), Lymphoma Diagnosis and Treatment (5 papers), DNA Repair Mechanisms (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Oncology (1.0k citations), Toxicology (135 citations), Otorhinolaryngology (91 citations), Molecular Biology (1.3k citations) and Cancer Research (238 citations). Daniel Glaubiger has collaborated with scholars based in United States, Malaysia and India. Frequent co-authors include Kurt W. Kohn, Warren E. Ross, A Ramu, Z Fuks, David G. Poplack, Ian Magrath, Michael J. Waring, John S. Holcenberg, Charles A. Friedman and Riccardo Riccardi. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics, Biopolymers, Journal of Surgical Oncology and Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.